Related references
Note: Only part of the references are listed.A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management
Benjamin Garmezy et al.
BLOOD REVIEWS (2021)
Is there a gender effect in polycythemia vera?
Francesca Palandri et al.
ANNALS OF HEMATOLOGY (2021)
Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management
Ayalew Tefferi
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Differential expression of circular RNAs in bone marrow-derived exosomes from essential thrombocythemia patients
Qiang Wang et al.
CELL BIOLOGY INTERNATIONAL (2021)
The Microenvironment in Myeloproliferative Neoplasms
Gajalakshmi Ramanathan et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
Rory M. Shallis et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms
Andrew Schafer
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
The Role of Megakaryocytes in Myelofibrosis
Johanna Melo-Cardenas et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy
Stefania Trino et al.
LEUKEMIA (2021)
Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies
Vincenzo Nasillo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology
Theodoros Karantanos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease
Dorian Forte et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms
Alexandre Guy et al.
LEUKEMIA (2021)
Polycythaemia vera: molecular genetics, diagnostics and therapeutics
Jeffrey S. Putter et al.
VOX SANGUINIS (2021)
A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms
Ana Guijarro-Hernandez et al.
CANCERS (2021)
Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia
Douglas Tremblay et al.
FRONTIERS IN ONCOLOGY (2021)
Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature
Samah Alimam et al.
BLOOD ADVANCES (2021)
Exosomes: Isolation, characterization, and biomedical applications
Ghadi N. Alzhrani et al.
CELL BIOLOGY INTERNATIONAL (2021)
The exosome journey: from biogenesis to uptake and intracellular signalling
Sonam Gurung et al.
CELL COMMUNICATION AND SIGNALING (2021)
Current Clinical Investigations in Myelofibrosis
Sangeetha Venugopal et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Genetics of Myeloproliferative Neoplasms
Jakub Szybinski et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Unmet Need in Essential Thrombocythemia and Polycythemia Vera
Ashwin Kishtagari et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
CircRNAs: role in human diseases and potential use as biomarkers
Lorena Verduci et al.
CELL DEATH & DISEASE (2021)
Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms
Brandi N. Reeves et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2021)
Role of ATP in Extracellular Vesicle Biogenesis and Dynamics
Marta Lombardi et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Vesicular Intelligence Strategy of Blood Cancers
Dorian Forte et al.
GENES (2021)
The role of lipids in exosome biology and intercellular communication: Function, analytics and applications
Javier Donoso-Quezada et al.
TRAFFIC (2021)
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Daniel Arthur Corpuz Fisher et al.
FRONTIERS IN IMMUNOLOGY (2021)
The ins and outs of microvesicles
James W. Clancy et al.
FASEB BIOADVANCES (2021)
Functional Consequences of Mutations in Myeloproliferative Neoplasms
Stefan N. Constantinescu et al.
HEMASPHERE (2021)
Low-Risk Essential Thrombocythemia: A Comprehensive Review
Andrew J. Robinson et al.
HEMASPHERE (2021)
Large extracellular vesicles: Size matters in tumor progression
Chiara Ciardiello et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Myelofibrosis biology and contemporary management
Naseema Gangat et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm
Johanne Poisson et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN
Helene F. E. Gleitz et al.
BLOOD (2020)
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Large Extracellular Vesicles-A New Frontier of Liquid Biopsy in Oncology
Gaetano Pezzicoli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Extracellular microvesicles/exosomes: discovery, disbelief, acceptance, and the future?
Mariusz Z. Ratajczak et al.
LEUKEMIA (2020)
Risks of Solid and Lymphoid Malignancies in Patients with Myeloproliferative Neoplasms: Clinical Implications
Mette Brabrand et al.
CANCERS (2020)
Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants
Elena Masselli et al.
CELLS (2020)
Uptake and Fate of Extracellular Membrane Vesicles: Nucleoplasmic Reticulum-Associated Late Endosomes as a New Gate to Intercellular Communication
Denis Corbeil et al.
CELLS (2020)
Communication between stromal and hematopoietic stem cell by exosomes in normal and malignant bone marrow niche
Vahid Niazi et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance
Elisa Rumi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data
Giuseppe G. Loscocco et al.
ONCOTARGETS AND THERAPY (2020)
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis
Martina Barone et al.
ONCOIMMUNOLOGY (2020)
High-throughput analysis and functional interpretation of extracellular vesicle content in hematological malignancies
Ilaria Tanasi et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling
Daniel A. C. Fisher et al.
LEUKEMIA (2019)
Reprogramming of GBM microenvironment by large oncosomes: 'Traveling' V-ATPases are doing more than acidification
Delphine Garnier
EBIOMEDICINE (2019)
New insights into extracellular vesicle biogenesis and function
Arash Latifkar et al.
JOURNAL OF CELL SCIENCE (2019)
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
Chiara Ciardiello et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasmas
Cansu Cimen Bozkus et al.
CANCER DISCOVERY (2019)
Essential Thrombocythemia
Ayalew Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Biological membranes in EV biogenesis, stability, uptake, and cargo transfer: an ISEV position paper arising from the ISEV membranes and EVs workshop
Ashley E. Russell et al.
JOURNAL OF EXTRACELLULAR VESICLES (2019)
Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis
Martina Barone et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Quantitative Proteomic Analysis of Small and Large Extracellular Vesicles (EVs) Reveals Enrichment of Adhesion Proteins in Small EVs
Lizandra Jimenez et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia vera
Jared S. Fowles et al.
LEUKEMIA (2019)
Comparison of Proteome Composition of Serum Enriched in Extracellular Vesicles Isolated from Polycythemia Vera Patients and Healthy Controls
Anna Fel et al.
PROTEOMES (2019)
Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm
Hew Yeng Lai et al.
BLOOD ADVANCES (2019)
Basics and applications of tumor-derived extracellular vesicles
Yu-Ling Tai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy
M. O. Holmstrom et al.
LEUKEMIA (2018)
Extracellular vesicles in the hematopoietic microenvironment
John T. Butler et al.
HAEMATOLOGICA (2018)
Extracellular vesicles in the hematopoietic microenvironment
John T. Butler et al.
HAEMATOLOGICA (2018)
Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies
Ilaria Laurenzana et al.
STEM CELLS INTERNATIONAL (2018)
The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition
Emmanouil Spanoudakis et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2018)
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
Maira da Costa Cacemiro et al.
HEMATOLOGY TRANSFUSION AND CELL THERAPY (2018)
Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma
Tatyana Vagner et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
M. O. Holmstrom et al.
LEUKEMIA (2017)
Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms
Yasuhiro Taniguchi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia
Andrea Piccin et al.
TRANSLATIONAL RESEARCH (2017)
Clinical significance of circulating microparticles in Ph-myeloproliferative neoplasms
Wenjuan Zhang et al.
ONCOLOGY LETTERS (2017)
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients
S. Cerquozzi et al.
BLOOD CANCER JOURNAL (2017)
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis
Marco Romano et al.
ONCOIMMUNOLOGY (2017)
Monocytosis in polycythemia vera: Clinical and molecular correlates
Daniela Barraco et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer
Valentina R. Minciacchi et al.
CANCER RESEARCH (2017)
PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells
Yi Fang et al.
ANGIOGENESIS (2016)
Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis
Margherita Massa et al.
BLOOD (2016)
Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia
Agnes Charpentier et al.
HAEMATOLOGICA (2016)
The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms
M. O. Holmstrom et al.
LEUKEMIA (2016)
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S. Koschmieder et al.
LEUKEMIA (2016)
Myeloid-derived suppressor cells in patients with myeloproliferative neoplasm
Jen Chin Wang et al.
LEUKEMIA RESEARCH (2016)
Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia
Agnes Charpentier et al.
HAEMATOLOGICA (2016)
Targeted deep sequencing in polycythemia vera and essential thrombocythemia
Ayalew Tefferi et al.
BLOOD ADVANCES (2016)
Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms: a single-centre experience
Jarmila Kissova et al.
BLOOD COAGULATION & FIBRINOLYSIS (2015)
Natural killer cells in patients with polycythemia vera
Carole Sanchez et al.
HUMAN IMMUNOLOGY (2015)
Mass-Spectrometry-Based Molecular Characterization of Extracellular Vesicles: Lipidomics and Proteomics
Simion Kreimer et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm
Angela G. Fleischman
MEDIATORS OF INFLAMMATION (2015)
Isolation and molecular characterization of extracellular vesicles
Douglas D. Taylor
METHODS (2015)
High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders
Antonella Caivano et al.
TUMOR BIOLOGY (2015)
Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia
Marina Marchetti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications
Emmanuel Pourcelot et al.
EXPERIMENTAL HEMATOLOGY (2014)
Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms
Lorena Arranz et al.
NATURE (2014)
An Immune Dysregulation in MPN
Giovanni Barosi
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2014)
Large oncosomes mediate intercellular transfer of functional microRNA
Matteo Morello et al.
CELL CYCLE (2013)
Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche
Koen Schepers et al.
CELL STEM CELL (2013)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders
David E. Connor et al.
THROMBOSIS RESEARCH (2013)
Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis
Rakhee Vaidya et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis
Animesh Pardanani et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α
Caroline Hasselbalch Riley et al.
BLOOD (2011)
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
Tiziano Barbui et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-β1
Miroslaw J. Szczepanski et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
Ayalew Tefferi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Platelet- and Megakaryocyte-Derived Microparticles
Robert Flaumenhaft et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Flow cytometry-evaluated platelet CD36 expression, reticulated platelets and platelet microparticles in essential thrombocythaemia and secondary thrombocytosis
Marie-Pierre Moles-Moreau et al.
THROMBOSIS RESEARCH (2010)
Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms
Jerome Duchemin et al.
THROMBOSIS RESEARCH (2010)
Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles
Robert Flaumenhaft et al.
BLOOD (2009)
Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia
Marijke C. Trappenburg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis
M. A. Elliott et al.
LEUKEMIA RESEARCH (2007)
MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients
Animesh D. Pardanani et al.
BLOOD (2006)
Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases
KE Panteli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Impaired NK cell differentiation of blood-derived CD34+ progenitors from patients with myeloid metaplasia with myelofibrosis
D Briard et al.
CLINICAL IMMUNOLOGY (2003)